89
Participants
Start Date
May 31, 2008
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
Enbrel
"The patients will be treated in accordance with the requirements of the labeling of Enbrel® in Austria. The dosage and duration of therapy is to be determined by the physician to meet the patients' individual needs for treatment.~To record complete dosing information, initial dose will be documented at baseline and any change will be documented with date, dose and reason at the subsequent visits."
Lead Sponsor
Pfizer
INDUSTRY